Literature DB >> 6184004

Continuous subcutaneous infusion of morphine for the pain of terminal malignancy.

C F Campbell, J B Mason, J M Weiler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6184004     DOI： 10.7326/0003-4819-98-1-51

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  7 in total

1.  Syringe driver in terminal care.

Authors:  S B Dover
Journal:  Br Med J (Clin Res Ed)       Date:  1987-02-28

2.  Continuous subcutaneous injection of ketamine for cancer pain.

Authors:  E Oshima; K Tei; H Kayazawa; N Urabe
Journal:  Can J Anaesth       Date:  1990-04       Impact factor: 5.063

3.  Suffering and dying in cancer patients. Research frontiers in controlling confusion, cachexia, and dyspnea.

Authors:  N MacDonald
Journal:  West J Med       Date:  1995-09

4.  Subcutaneous narcotic infusions for cancer pain: treatment outcome and guidelines for use.

Authors:  D E Moulin; N G Johnson; N Murray-Parsons; M F Geoghegan; V A Goodwin; M A Chester
Journal:  CMAJ       Date:  1992-03-15       Impact factor: 8.262

Review 5.  Patient-controlled analgesia. Pharmacokinetic and therapeutic considerations.

Authors:  H F Hill; L E Mather
Journal:  Clin Pharmacokinet       Date:  1993-02       Impact factor: 6.447

Review 6.  Drug management of pain in cancer patients.

Authors:  C B Tuttle
Journal:  Can Med Assoc J       Date:  1985-01-15       Impact factor: 8.262

7.  Pharmacokinetics of Morphine, Morphine-3-Glucuronide and Morphine-6-Glucuronide in Terminally Ill Adult Patients.

Authors:  Linda G Franken; Anniek D Masman; Brenda C M de Winter; Birgit C P Koch; Frans P M Baar; Dick Tibboel; Teun van Gelder; Ron A A Mathot
Journal:  Clin Pharmacokinet       Date:  2016-06       Impact factor: 6.447
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.